Anticorps Recombinant de lapin anti-LIFR

LIFR Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

250110B11

N° de cat : 85827-2-PBS

Synonymes

CD118, LIF R, LIF receptor, LIF-R, SJS2



Informations sur le produit

85827-2-PBS cible LIFR dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène LIFR Protéine recombinante Eg2599
Nom complet leukemia inhibitory factor receptor alpha
Masse moléculaire calculée124 kDa
Poids moléculaire observé190 kDa, 170 kDa
Numéro d’acquisition GenBankNM_001127671.1
Symbole du gène LIFR
Identification du gène (NCBI) 3977
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

LIFR, also known as CD118, is a subunit of a receptor for leukemia inhibitory factor (LIF). LIF is a pleiotropic cytokine of the interleukin-6 family that affects the differentiation, survival, and proliferation of a wide variety of cells in the adult and the embryo. LIFR is the low-affinity binding chain that, together with the high-affinity converter subunit gp130, forms a high-affinity receptor complex that mediates the action of LIF. The high-affinity complex also binds a related cytokine, oncostatin M (PMID: 8999038). LIFR has also been identified as a breast cancer metastasis suppressor that functions through the HIPPO-YAP pathway (PMID: 23001183). LIFR appeared as doublets with 190 and 170 kDa (PMID: 10858440). They represented different glycosylated forms of the LIFR in different steps of protein maturation.

{{ptg:RelatedPrimaryAntibodies}}